NCT02232776View on ClinicalTrials.gov

Efficacy and Safety of Losartan in Children With Ig A Nephropathy

PHASE3CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

April 30, 2017

Conditions
Glomerulonephritis, IGA
Interventions
DRUG

Losartan

Dose of Losartan : 0.7mg/kg once daily.

Trial Locations (1)

Unknown

Seoul National University Children's Hospital, Seoul

All Listed Sponsors
collaborator

Ministry of Food and Drug Safety, Korea

OTHER_GOV

lead

Seoul National University Hospital

OTHER

NCT02232776 - Efficacy and Safety of Losartan in Children With Ig A Nephropathy | Biotech Hunter | Biotech Hunter